AMR Action Fund
Jaclyn Levy joins the Fund from the Infectious Diseases Society of America (IDSA), where she served as Director of Public Policy and advanced a broad portfolio of science and public health policy issues. Prior to IDSA, Jaclyn worked as a biosecurity analyst for the U.S. Department of Homeland Security and as a scientific editor and consultant. She has over a decade of experience in federal and global policy and advocacy work and has authored numerous publications on pandemic preparedness, antimicrobial resistance, molecular diagnostics, and biomedical R&D.
Jaclyn holds a BA from The George Washington University and an MS in Biohazardous Threat Agents & Emerging Infectious Diseases from Georgetown University. She was selected as a 2020 Atlantic Council Millennium Fellow.
This person is not in any teams
This person is not in any offices
AMR Action Fund
The AMR Action Fund is a ground-breaking collective venture launched by more than 20 leading pharmaceutical companies to bring 2 to 4 new antibiotics to patients by the end of the decade.